What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences

Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

The international journal of lower extremity wounds - (2024) vom: 28. Feb., Seite 15347346241233938

Sprache:

Englisch

Beteiligte Personen:

Rebelos, Eleni [VerfasserIn]
Anastasiou, Ioanna A [VerfasserIn]
Tentolouris, Anastasios [VerfasserIn]
Papanas, Nikolaos [VerfasserIn]
Jude, Edward [VerfasserIn]

Links:

Volltext

Themen:

Advanced glycation end products
Cardiac autonomic neuropathy
Charcot neuroarthropathy
Diabetes
Diabetic neuropathy
Journal Article
Review

Anmerkungen:

Date Revised 28.02.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1177/15347346241233938

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369043022